ProCE Banner Activity

DeFi: Long-term Follow-up of Nirogacestat for Adults With Desmoid Tumors

Conference Coverage
Slideset

Extended follow-up of the phase III DeFi trial showed further reduced tumor size, durable responses, and improved quality of life with continued nirogacestat treatment for patients with progressive desmoid tumors.

Released: November 26, 2024

Expiration: November 25, 2025

Share

Provided by

Provided by Clinical Care Options, LLC.

ProCE Banner

Supporters

Supported by an educational grant from SpringWorks Therapeutics, Inc.

SpringWorks Therapeutics, Inc.